Role of brain dopaminergic system in the adrenomedullin-induced diuresis and natriuresis

Pharmacological Research

Volumn 48, Issue 5, 2003, Pages 489-496

  Diáz, Emilia ^a   Silva, Mariá ^a   Israel, Anita ^a  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

Adrenomedullin; Dopaminergic denervation; Dopaminergic involvement; Haloperidol; Remoxipride; SCH 23390; Sulpiride

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADRENOMEDULLIN; DESIPRAMINE; DOPAMINE; HALOPERIDOL; NORADRENALIN; OXIDOPAMINE; REMOXIPRIDE; SULPIRIDE;

ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; DENERVATION; DIURESIS; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; MALE; NATRIURESIS; NONHUMAN; NORADRENALIN BRAIN LEVEL; PRIORITY JOURNAL; RAT; SODIUM EXCRETION; URINE VOLUME;

EID: 0041826995     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-6618(03)00186-5     Document Type: Article

References (42)

1. Ichiki Y., Kitamura K., Kangawa K., Kawamoto M., Matsuo H., Eto T. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett. 338:1994;6-10.
2. Kitamura K., Sakata J., Kangawa K., Kojima H., Matsuo H., Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem. Biophys. Res. Commun. 194:1993;720-725.
3. Satoh F., Takahashi K., Murakami O., Totsune K., Sone M., Ohneda M.et al. Adrenomedullin in human brain, adrenal glands and tumor tissues of pheochromocytoma, ganglioneuroblastoma and neuroblastoma. J. Clin. Endocrinol. Metabol. 80:1995;1750-1752.
4. Satoh F., Takahashi K., Murakami O., Totsune K., Sone M., Ohneda M.et al. Immunocytochemical localization of adrenomedullin-like immunoreactivity in the human hypothalamus and the adrenal gland. Neurosci. Lett. 203:1996;207-210.
5. Hwang I.S., Tang F. The distribution and gene expression of adrenomedullin in the rat brain: peptide/mRNA and precursor/active peptide relationships. Neurosci. Lett. 267:1999;85-88.
6. Ueta Y., Kitamura K., Isse T., Shibuya I., Kabashima N., Yamamoto S.et al. Adrenomedullin-immunoreactive neurons in the paraventricular and supraoptic nuclei of the rat. Neurosci. Lett. 202:1995;37-40.
7. Owji A.A., Smith D.M., Coppock H.A., Morgan G.A., Bhogal R., Ghatei M.A.et al. An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology. 136:1995;2127-2134.
8. 1 receptor and adrenomedullin receptor mRNAs in the rat central nervous system. Mol. Brain Res. 57:1998;149-154.
9. Takahashi K., Satoh F., Sone M., Murakami O., Sasano H., Mouri T.et al. Expression of adrenomedullin mRNA in the human brain and pituitary. Peptide. 18:1997;1051-1053.
10. Samson W.K., Murphy T.C. Adrenomedullin inhibits salt appetite. Endocrinology. 138:1997;613-616.
11. Samson W.K. Adrenomedullin and the control of fluid and electrolyte homeostasis. Annu. Rev. Physiol. 61:1999;363-389.
12. Murphy T.C., Samson W.K. The novel vasoactive hormone, adrenomedullin, inhibits water drinking in the rat. Endocrinology. 136:1995;2459-2463.
13. Yokoi H., Arima T., Kondo K., Iwasaki Y., Oiso Y. Intracerebroventricular injection of adrenomedullin inhibits vasopressin release in conscious rats. Neurosci. Lett. 216:1996;65-67.
14. Charles C.J., Rademaker M.T., Richards A.M., Cooper G.J., Coy D.H., Nicholls M.G. Hemodynamic, hormonal, and renal effects of intracerebroventricular adrenomedullin in conscious sheep. Endocrinology. 139:1998;1746-1751.
15. Saita M., Shimokawa A., Kunitake T., Kato K., Hanamori T., Kitamura K.et al. Central actions of adrenomedullin on cardiovascular parameters and sympathetic outflow in conscious rats. Am. J. Physiol. 274:1998;R979-R984. [Regul Integr Compar Physiol 43].
16. Israel A., Díaz E. Diuretic and natriuretic action of adrenomedullin administered intracerebroventricularly in conscious rats. Regul. Pept. 89:2000;13-18.
17. Morris M., McCann S.M., Orias R. Role of transmitters in mediating hypothalamic control of electrolyte excretion. Can. J. Physiol. Pharmacol. 55:1977;1143-1149.
18. Van den Buuse M, de Jong W. Pharmacology of central dopaminergic modulation in hypertension. In: Saito H, Minami M, Parvez SH, editors. Antihypertensive drugs today. Utrech, The Netherlands, Tokyo, Japan: VSP Press; 1992. p. 157-88.
19. Fitzsimons J.T., Setler P.E. The relative importance of central nervous catecholaminergic and cholinergic mechanism in drinking in response to angiotensin and other thirst stimuli. J. Physiol. 250:1975;613-631.
20. Forsling M.L., Williams H. Central effects of dopamine on vasopressin release in the normally hydrated and water-loaded rat. J. Physiol. 346:1984;49-59.
21. Buijs R.M., Geffard M., Pool C.W., Hoorneman E.M. The dopaminergic innervation of the supraoptic and paraventricular nucleus. A light and electron microscopical study. Brain Res. 323:1984;65-72.
22. Melis M.R., Argiolas A., Gessa G.L. Apomorphine increases plasma oxytocin concentration in male rats. Neurosci. Lett. 10:1989;351-355.
23. Clarke G., Lincoln G.W., Merrick L.P. Dopaminergic control of oxytocin release in lactating rats. J. Endocrinol. 83:1979;409-420.
24. Yamaguchi K., Hama H., Watanabe K. Possible contribution of dopaminergic receptors in the anteroventral third ventricular region to hyperosmolality-induced vasopressin secretion in conscious rats. Eur. J. Endocrinol. 134:1996;243-250.
25. Breese G.R., Traylor T.D. Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine. Br. J. Pharmacol. 42:1971;88-99.
26. Annunziato L. Regulation of the tubero-infundibular and nigrostriatal systems: evidence for different kinds of dopaminergic: neurons in the brain. Neuroendocrinology. 29:1979;66-76.
27. DiBussolo J.M., Gant J.R., Kerber J.D. Instrumental considerations in catecholamine analysis using liquid chromatography with electrochemical detection. Chromatogr. News Lett. 11:1983;13-27.
28. Lowry O.H., Rosenbrough N.J., Farr A., Randll R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
29. Yamaguchi T., Baba K., Doi Y., Yano K., Kitamura K., Eto T. Inhibition of aldosterone production by adrenomedullin, a hypotensive peptide, in the rat. Hypertension. 28:1996;308-314.
30. Lindvall O., Bjorklund A., Skagerberg G. Selective histochemical demonstration of dopamine terminal systems in rat di- and telencephalon: new evidence for dopaminergic innervation of hypothalamic neurosecretory nuclei. Brain Res. 306:1984;19-30.
31. Torres M., Barbella Y., Israel A. Dopaminergic mediation of diuretic and natriuretic action of centrally administered rat atrial natriuretic factor (99-126). Proc. Soc. Exp. Biol. Med. 190:1989;18-22.
32. Bridges T.E., Hillhouse E.W., Jones M.T. The effect of dopamine on neurohypophyseal hormone release in vivo and from at neuronal lobe and hypothalamus in vitro. J. Physiol. (Lond.). 260:1975;647-666.
33. Mason W.T. Excitation by dopamine of putative oxytocinergic neurons in the rat supraoptic nucleus in vitro: evidence for two classes of continuously firing neurons. Brain Res. 267:1983;113-121.
34. Moos F., Richard Ph. Excitatory effect of dopamine on oxytocin and vasopressin reflex releases in the rat. Brain Res. 242:1982;249-266.
35. Civelli O., Bunzow J.R., Grandy D.K. Molecular diversity of the dopamine receptors. Ann. Rev. Pharmacol. Toxicol. 33:1993;281-301.
36. Richtand N.M., Kelsoe J.R., Segal D.S., Kuczenski R. Regional quantification of D1, D2 and D3 dopamine receptor mRNA in rat brain using a ribonuclease protection assay. Mol. Brain Res. 33:1995;97-103.
37. O'Connell D.P. Expression of newly cloned brain dopamine receptors in peripheral organs. Biochem. Soc. Trans. 24:1996;169-172.
38. Hentschel K., Fleckenstein A.E., Toney T.W., Lawson D.M., Moore K.E., Lookingland K.J. Prolactin regulation of tuberoinfundibular dopaminergic neurons: immunoneutralization studies. Brain Res. 852:2000;28-36.
39. 2 receptors in the regulation of hypothalamic tuberoinfundibular dopamine neurons. Eur. J. Pharmacol. 355:1998;141-147.
40. Yuan Z.F., Pan J.-T. Stimulatory effect of central oxytocin on tuberoinfundibular dopaminergic neuron activity and inhibition on prolactin secretion: neurochemical and electrophysiological studies. Endocrinology. 137:1996;4120-4125.
41. Horrobin D.F. Prolactin as a regulator of fluid and electrolyte metabolism in mammals. Fed. Proc. 39:1980;2567-2570.
42. Windle R.J., Judah J.M., Forsling M.L. Effect of oxytocin receptor antagonists on the renal actions of oxytocin and vasopressin in the rat. J. Endocrinol. 152:1997;257-264.